DRUG APPROVALS
May 17, 2019
Acute Myeloid Leukemia: From Molecular Pathogenesis to Oral Targeted Therapies
The frequent occurrence of mutations and gene alterations has spurred the development of novel agents for the treatment of AML, including new oral targeted therapies that have recently received regulatory approval.October 16, 2018
Review of Selected NMEs 2018
October 16, 2018
New Drug Review 2018
October 13, 2017
New Drug Review 2017
October 13, 2017
Review of Selected NMEs 2017
October 14, 2016
Review of Selected NMEs 2016
October 14, 2016
New Drug Review 2016
October 16, 2015
New Drug Review 2015
October 16, 2015
Review of Selected NMEs 2015
October 16, 2014
New Drug Review 2014
October 16, 2014
Review of Selected NMEs 2014
October 18, 2013
New Drug Review 2013
October 18, 2013
Review of Selected NMEs 2013
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.